Publications by authors named "Ananya Murthy"

The International Society of Pharmacometrics (ISoP) Mentorship Program (IMP) aims to help professionals at all career stages to transition into the pharmacometrics field, move to a different role/area within pharmacometrics, or expand their skillsets. The program connects mentees at various stages of their careers with mentors based on established criteria for mentor-mentee matching. Pairing mentees with appropriate mentors ensures strong alignment between mentees' interests and mentors' expertise as this is critical to the success and continuation of the relationship between the mentor and mentee.

View Article and Find Full Text PDF

Glioblastoma (GBM) is the most common primary brain tumor and has a poor prognosis; as such, there is an urgent need to develop innovative new therapies. Tumoricidal stem cells are an emerging therapy that has the potential to combat limitations of traditional local and systemic chemotherapeutic strategies for GBM by providing a source for high, sustained concentrations of tumoricidal agents locally to the tumor. One major roadblock for tumoricidal stem cell therapy is that the persistence of tumoricidal stem cells injected as a cell suspension into the GBM surgical resection cavity is limited.

View Article and Find Full Text PDF

Glioblastoma (GBM) is a highly aggressive and heterogeneous form of brain cancer. Genotypic and phenotypic heterogeneity drives drug resistance and tumor recurrence. Combination chemotherapy could overcome drug resistance; however, GBM's location behind the blood-brain barrier severely limits chemotherapeutic options.

View Article and Find Full Text PDF
Article Synopsis
  • Tumoricidal neural stem cells (NSCs) genetically engineered to release tumor-fighting agents are being developed as a treatment for glioblastoma (GBM), targeting residual tumors post-surgery.
  • The study explored how different degradation rates of composite acetalated dextran gelatin scaffolds influence NSC viability in the brain; fast-degrading scaffolds dissolved in a week, while slow ones lasted over 56 days.
  • NSCs delivered via scaffolds showed improved persistence compared to direct injection, with the scaffolds enhancing NSC implantation efficiency and sustaining their presence in the brain for up to 120 days post-implantation.
View Article and Find Full Text PDF